163 related articles for article (PubMed ID: 37688927)
21. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
Watanabe M; Nakamura Y; Michalak Z; Isobe N; Barro C; Leppert D; Matsushita T; Hayashi F; Yamasaki R; Kuhle J; Kira JI
Neurology; 2019 Sep; 93(13):e1299-e1311. PubMed ID: 31471502
[TBL] [Abstract][Full Text] [Related]
22. Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
Schindler P; Aktas O; Ringelstein M; Wildemann B; Jarius S; Paul F; Ruprecht K
Expert Rev Clin Immunol; 2023 Jan; 19(1):71-91. PubMed ID: 36378751
[TBL] [Abstract][Full Text] [Related]
23. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
24. Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort.
Arroyo Pereiro P; Muñoz-Vendrell A; León Moreno I; Bau L; Matas E; Romero-Pinel L; Martínez Yélamos A; Martínez Yélamos S; Andrés-Benito P
J Neurol; 2024 Apr; 271(4):1599-1609. PubMed ID: 38085343
[TBL] [Abstract][Full Text] [Related]
25. Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.
Niiranen M; Kontkanen A; Jääskeläinen O; Tertsunen HM; Selander T; Hartikainen P; Huber N; Solje E; Haapasalo A; Kokkola T; Lohioja T; Herukka SK; Simula S; Remes AM
Mult Scler Relat Disord; 2021 Nov; 56():103280. PubMed ID: 34627002
[TBL] [Abstract][Full Text] [Related]
26. Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.
Abdelhak A; Antweiler K; Kowarik MC; Senel M; Havla J; Zettl UK; Kleiter I; Skripuletz T; Haarmann A; Stahmann A; Huss A; Gingele S; Krumbholz M; Benkert P; Kuhle J; Friede T; Ludolph AC; Ziemann U; Kümpfel T; Tumani H
Ann Clin Transl Neurol; 2024 Feb; 11(2):477-485. PubMed ID: 38111972
[TBL] [Abstract][Full Text] [Related]
27. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
Yang X; Huang Q; Yang H; Liu S; Chen B; Liu T; Yang J; Yao H; Lin S; Chen X; Zhuang H; Long Y; Gao C
Mult Scler Relat Disord; 2019 Apr; 29():94-99. PubMed ID: 30690341
[TBL] [Abstract][Full Text] [Related]
28. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
29. Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study.
Simone M; De Giacomo A; Palumbi R; Palazzo C; Lucisano G; Pompamea F; Micella S; Pascali M; Gabellone A; Marzulli L; Giordano P; Gargano CD; Margari L; Frigeri A; Ruggieri M
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769380
[TBL] [Abstract][Full Text] [Related]
30. Disease characteristics of idiopathic transverse myelitis with serum neuronal and astroglial damage biomarkers.
Kim KW; Lee EJ; Kim SY; Jung HJ; Kim HJ; Kim S; Kim H; Seo D; So J; Kim J; Kim H; Kim KK; Lim YM
Sci Rep; 2023 Mar; 13(1):3988. PubMed ID: 36894677
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
[TBL] [Abstract][Full Text] [Related]
32. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
[TBL] [Abstract][Full Text] [Related]
33. Brain-derived neurotrophic factor, neurofilament light and glial fibrillary acidic protein do not change in response to aerobic training in people with MS-related fatigue - a secondary analysis of a randomized controlled trial.
Gravesteijn AS; Beckerman H; Willemse EA; Hulst HE; de Jong BA; Teunissen CE; de Groot V
Mult Scler Relat Disord; 2023 Feb; 70():104489. PubMed ID: 36621163
[TBL] [Abstract][Full Text] [Related]
34. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
35. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
36. Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.
van Ballegoij WJC; van de Stadt SIW; Huffnagel IC; Kemp S; Willemse EAJ; Teunissen CE; Engelen M
Ann Clin Transl Neurol; 2020 Nov; 7(11):2127-2136. PubMed ID: 33047897
[TBL] [Abstract][Full Text] [Related]
37. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
38. Neurofilament and glial fibrillary acidic protein in multiple sclerosis.
Norgren N; Sundström P; Svenningsson A; Rosengren L; Stigbrand T; Gunnarsson M
Neurology; 2004 Nov; 63(9):1586-90. PubMed ID: 15534240
[TBL] [Abstract][Full Text] [Related]
39. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Hyun JW; Kim SH; Huh SY; Kim W; Yun J; Joung A; Sato DK; Fujihara K; Kim HJ
Mult Scler; 2015 May; 21(6):710-7. PubMed ID: 25305252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
